Assel Kassymova

Dr. Assel Kassymova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
JMJamilya Mansurova
Jamilya Mansurova
AOAndrey Orekhov
Andrey Orekhov
AZA S Zhunuspekova
A S Zhunuspekova
AKAssel Kassymova
Assel Kassymova
LKL K Karazhanova
L K Karazhanova
Background: The objective of this study is to examine the impact of medication adherence on the timing of non-cardiovascular serious events (NCDS) onset in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods: This prospective study was conducted at a single center and involved 220 ACS patients who underwent sequential PCI with stenting. The Morisky Green Levine Medication Adherence Scale was employed to assess adherence to dual antiplatelet therapy (DAPT) and its impact on NCDS occurrence. Early in their hospitalization, all patients received education at the Coronary Heart Disease School. The survival rates of patients in both the main group and a control group (n=355) were subsequently evaluated. Results: The study findings indicated an inverse relationship between stent thrombosis development (Rho=− 0.334; p=0.001) and the timing of recurrent myocardial ischemia. There was also an inverse correlation between patient adherence and stent thrombosis development (Rho=− 0.275; p=0.009). Non-adherent individuals had a 16.8 times higher likelihood of experiencing stent thrombosis compared to compliant patients (p< 0.001). Following participation in the CHD School program, treatment adherence increased from 56.5% to 88.2%. Education for ACS patients post-stenting was significantly associated with all-cause mortality within the first 6 months (p=0.040). Conclusion: Secondary preventive measures, including education, impact the success of endovascular interventions in both the early hospital phase and the long term. Patient education can serve as a supplementary intervention to enhance DAPT adherence, thus diminishing the risk of recurrent cardiovascular events and mortality post endovascular intervention.

19 March 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AKAssel Kassymova
Assel Kassymova
JMJamilya Mansurova
Jamilya Mansurova
LKL. K. Karazhanova
L. K. Karazhanova
ACAssel Chinybayeva
Assel Chinybayeva
According to recommendations of ESC 2020-year, de-escalation of therapy with a P2Y12 receptor inhibitor (transition from prasugrel or ticagrelor to clopidogrel) It can be considered as an alternative strategy of dual antiplatelet therapy (DAPT) for patients with acute coronary syndrome (ACS) who are unsuitable for the use of a strong platelet inhibitor.De-escalation can be performed based on an individual clinical evaluation under the supervision of platelet function testing or CYP2C19 genotyping, depending on the patient’s risk profile and the availability of appropriate diagnostic methods. The optimal dosage of strong P2Y12 receptor inhibitors, such as ticagrelor or prasugrel is not entirely clear and is especially difficult to define for patients of Asian nationality.The article describes a clinical case of antiplatelet therapy de-escalation, particularly a dose reduction of the potent P2Y12 receptor inhibitor ticagrelor in a patient after percutaneous coronary intervention (PCI) with a high risk of bleeding based on platelet function determination and genetic testing. A 47-year-old patient of Kazakh nationality was hospitalized with gastrointestinal bleeding.Given bleeding type 3 by BARC (Bleeding Academic Research Consortium) associated with DAPT, it was decided to apply a strategy to de-escalate antiplatelet therapy under the control of platelet function testing (PFT) and genetic testing.In this case, replacement of ticagrelor with the weak P2Y12 receptor inhibitor clopidogrel was not possible as the patient appeared to be a carrier of the CYP2C19*2 polymorphism contributing to loss of function of the cytochrome P-450(CYP) enzyme.

11 May 2026 in Law, State and Telecommunications Review
Verified
Journal Article
Open access
PDF file
DKDauren Kozhabekov
Dauren Kozhabekov
ABAliya Bayseitova
Aliya Bayseitova
ASAidar Saitbekov
Aidar Saitbekov
AKAssel Kassymova
Assel Kassymova
EAElvira Alimova
Elvira Alimova
[Purpose] The research presents a fundamental theoretical and empirical study of the issues of operational and investigative activities in the context of countering the latest forms of organised crime in the digital space. [Methodology/approach/design] A scientific analysis is made of the conceptual and categorical apparatus and essential characteristics of operational and investigative measures used to detect, document and suppress criminal activity in the context of the digital transformation of society. The methodological foundations and structural elements of the system of operational and investigative measures are examined, with due regard for the specifics of the digital environment and the peculiarities of modern organised criminal groups [Findings] On the basis of a comprehensive comparative legal analysis of Kazakh and international legislation, the peculiarities of regulatory and legal regulation of the activities of operational and investigative units in the field of combating organised crime in the digital space are revealed. Key areas for modernisation of criminal, criminal procedure and operational search legislation are identified to improve the efficiency of law enforcement in the context of digitalisation of crime. In the context of international cooperation, the current state of interaction between law enforcement agencies of different countries in combating transnational organised crime is analysed, promising areas for the development of interstate cooperation and mechanisms for improving its effectiveness are identified. Specific recommendations are formulated for optimising the use of special technical means and information technologies in the process of documenting the illegal activities of organised criminal groups. As a result of the study, the role and importance of operational and investigative units of internal affairs bodies in the system of combating organised crime in the digital space are defined, and scientifically sound proposals for improving their activities are developed. [Practical implications] The recommendations are formulated for modernising the tactics and methods of conducting operational and investigative measures aimed at identifying and documenting new forms of criminal activity in the digital environment. A set of organisational and legal measures is proposed to improve the effectiveness of preventive activities of law enforcement agencies in the field of combating organised crime in the context of the digital transformation of society. [Originality/value] The study provides a longitudinal analysis of cybercrime trends in relation to major global events, and links the rise in cyber incidents to geopolitical and economic disruptions.

30 June 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
AKA.D. Kozhabayeva
A.D. Kozhabayeva
JMJamilya Mansurova
Jamilya Mansurova
AZA.S. Zhunuspekova
A.S. Zhunuspekova
AOAndrey Orekhov
Andrey Orekhov
AKAssel Kassymova
Assel Kassymova
LKL.K. Karazhanova
L.K. Karazhanova
Introduction.Inrecentyears,therehasbeenagrowingnumberofstudiesaimedatidentifyingandevaluatingnovelbiomarkersofcardiovasculardiseases,particularlyheartfailure.Thistrendisdrivenbytheneedtoenhancediagnosticaccuracy,riskstratification,andpersonalizedtreatmentapproaches.Amongthesebiomarkers,specialattentionisgiventothesolubleformoftheST2receptor(sST2),whichhasdemonstratedsignificantprognosticvalueacrossvariousformsofheartfailure.ThisreviewfocusesontheanalysisofcurrentdataregardingtheclinicalrelevanceofsST2andtheprospectsforitsimplementationinroutinemedicalpractice. Aim.AnalysisofliteraturedataonthebiomarkersST2asapredictorofadverseclinicaloutcomesinpatientswithheartfailure. SearchStrategy.AliteraturesearchwasconductedusingthescientificdatabasesPubMed,WebofScience,andGoogleScholar,aswellaselectronicscientificlibrarieseLibraryandCyberLeninka.Thesearchcoveredafive-yearperiod(2019–2024)andfocusedoncardiorenalbiomarkersaspredictorsofadverseoutcomesincardiovasculardiseases. Results.ThisliteraturereviewanalyzesstudiesontheprognosticsignificanceofthesST2biomarkerinpatientswithheartfailure.ThefindingsindicatethatsST2reflectskeypathophysiologicalprocesses,includingmyocardialfibrosisandsystemicinflammation.Evidence from the literature suggests that the integration of sST2 into clinical assessment improves early identification of patients at risk, refines prognostic accuracy, and facilitates ongoing patient monitoring.Theintegrationofthisbiomarkerintoclinicalpracticeoffersopportunitiesformorepreciseriskstratificationandapersonalizedapproachtotreatment. Conclusions.AreviewofcontemporaryliteratureonclinicalandlaboratorypredictorsofheartfailuredemonstratesthatthebiomarkersST2hashighdiagnosticandprognosticsignificance.Itreflectsmyocardialfibrosisandsystemicinflammation—processescloselyassociatedwiththeprogressionofheartfailure.Furtherresearchisneededtodetermineoptimalthresholdvalues,validateassessmentmethodologies,andintegratesST2intostandardizedclinicalalgorithms. Введение. В последние годы наблюдается рост числа исследований, направленных на выявление и оценку новых биомаркеров сердечно-сосудистых заболеваний, в частности сердечной недостаточности. Такая тенденция обусловлена необходимостью повышения точности диагностики, стратификации риска и персонализации терапии. Среди биомаркеров особый интерес вызывает растворимая форма рецептора ST2 (sST2), демонстрирующая высокую прогностическую ценность при различных формах сердечной недостаточности. Настоящий обзор посвящён анализу актуальных данных о клинической роли sST2 и перспективам его применения в рутинной практике. Цель. Анализ литературных данных о биомаркере sST2 как предикторе неблагоприятных клинических исходов у пациентов с сердечной недостаточностью. Стратегия поиска. Проведен поиск научных публикаций в поисковых системах PubMed, WebofScience, GoogleScholar, в электронных научных библиотеках eLibrary, СyberLeninka. Глубина поиска 5 лет (2019-2024). Поиск информации о кардиоренальных маркерах как предикторах неблагоприятных исходов при сердечно-сосудистых заболеваниях. Результаты. В настоящем литературном обзоре проанализированы исследования, посвящённые прогностической значимости биомаркера sST2 у пациентов с сердечной недостаточностью. Показано, что sST2 отражает ключевые патофизиологические процессы, включая фиброз миокарда и системное воспаление. Данные литературы подтверждают, что применение sST2 в диагностике и прогнозировании неблагоприятных клинических исходов способствует более раннему выявлению риска, уточнению прогноза и динамическому наблюдению за пациентами. Внедрение этого биомаркера в клиническую практику открывает возможности для более точной стратификации риска и персонализированного подхода к лечению. Выводы. Обзор современной литературы по клинико-лабораторным предикторам сердечной недостаточности показывает, что биомаркер sST2 обладает высокой диагностической и прогностической значимостью. Он отражает процессы миокардиального фиброза и системного воспаления, ассоциированные с прогрессированием сердечной недостаточности. Дальнейшие исследования необходимы для уточнения пороговых значений, валидации методов оценки и интеграции sST2 в...

Verified
Journal Article
Open access
PDF file
JMJamilya Mansurova
Jamilya Mansurova
AKAnar Kozhabayeva
Anar Kozhabayeva
MKMirgul Kapakova
Mirgul Kapakova
AZAisulu Zhunuspekova
Aisulu Zhunuspekova
AAAinur Abylkhairova
Ainur Abylkhairova
AKAssel Kassymova
Assel Kassymova
Background: Whether plasma α-Klotho carries prognostic value in patients with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI) is still unclear. Objectives: We set out to examine the links between plasma α-Klotho levels, routine clinical and laboratory findings, the occurrence of acute kidney injury (AKI), and cardiovascular mortality after PCI. Methods: Eighty-six patients with ACS treated by PCI were enrolled in this prospective study. Plasma α-Klotho was measured within 48 h of the procedure. Relationships were assessed by correlation analysis and logistic regression; cardiovascular mortality was tracked for 12 months. Results: Acute kidney injury developed in 30 patients (34.9%), and nine cardiovascular deaths (10.5%) occurred during the year of follow-up. α-Klotho showed positive correlations with platelet count, triglycerides and total protein, and inverse correlations with FIB-4, aspartate aminotransferase, creatinine, GRACE score, contrast volume and international normalized ratio. No significant link was found between α-Klotho and AKI (p = 0.882). Erythrocyte sedimentation rate (OR = 1.090; p < 0.001) and contrast volume (OR = 1.014; p = 0.007) remained independently associated with AKI. In univariable analysis higher α-Klotho levels were linked to lower cardiovascular mortality (OR = 0.648; p = 0.009). Conclusions: Higher plasma α-Klotho concentrations were associated with reduced odds of cardiovascular death in the univariable model. No association with AKI was detected. The mortality results should be regarded as exploratory and do not demonstrate an independent prognostic role.